A prospective study on the epidemiology and clinical significance of viral respiratory infections among pediatric oncology patients

2019 ◽  
Vol 36 (3) ◽  
pp. 173-186 ◽  
Author(s):  
Christianna Vliora ◽  
Vassilios Papadakis ◽  
Dimitrios Doganis ◽  
Natalia Tourkantoni ◽  
Anna Paisiou ◽  
...  
1997 ◽  
Vol 16 (12) ◽  
pp. 1131-1134 ◽  
Author(s):  
DAVID BURGNER ◽  
STEVEN SIARAKAS ◽  
GILLIAN EAGLES ◽  
ANTHONY MCCARTHY ◽  
ROSS BRADBURY ◽  
...  

2016 ◽  
Vol 16 (1) ◽  
Author(s):  
Tina Uršič ◽  
Nina Gorišek Miksić ◽  
Lara Lusa ◽  
Franc Strle ◽  
Miroslav Petrovec

2017 ◽  
Vol 8 (2) ◽  
pp. 49
Author(s):  
Tayseer Alsaad ◽  
Mohamad Qaisuddin ◽  
Doua AlSaad ◽  
Prem Chandra ◽  
Omar AlAbd ◽  
...  

Author(s):  
Valentin Sencio ◽  
Marina Gomes Machado ◽  
François Trottein

AbstractBacteria that colonize the human gastrointestinal tract are essential for good health. The gut microbiota has a critical role in pulmonary immunity and host’s defense against viral respiratory infections. The gut microbiota’s composition and function can be profoundly affected in many disease settings, including acute infections, and these changes can aggravate the severity of the disease. Here, we discuss mechanisms by which the gut microbiota arms the lung to control viral respiratory infections. We summarize the impact of viral respiratory infections on the gut microbiota and discuss the potential mechanisms leading to alterations of gut microbiota’s composition and functions. We also discuss the effects of gut microbial imbalance on disease outcomes, including gastrointestinal disorders and secondary bacterial infections. Lastly, we discuss the potential role of the lung–gut axis in coronavirus disease 2019.


Sign in / Sign up

Export Citation Format

Share Document